BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6811438)

  • 1. Selection of nonmucoid derivatives of mucoid Pseudomonas aeruginosa is strongly influenced by the level of iron in the culture medium.
    Boyce JR; Miller RV
    Infect Immun; 1982 Aug; 37(2):695-701. PubMed ID: 6811438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility as a selective force in the reversion of cystic fibrosis-associated mucoid Pseudomonas aeruginosa to the nonmucoid phenotype in culture.
    Boyce JR; Miller RV
    Infect Immun; 1982 Aug; 37(2):840-4. PubMed ID: 6811443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa.
    Darzins A; Chakrabarty AM
    J Bacteriol; 1984 Jul; 159(1):9-18. PubMed ID: 6330052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aeration selects for mucoid phenotype of Pseudomonas aeruginosa.
    Krieg DP; Bass JA; Mattingly SJ
    J Clin Microbiol; 1986 Dec; 24(6):986-90. PubMed ID: 3097070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE; Chakrabarty AM
    Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    Miller RV; Rubero VJ
    J Clin Microbiol; 1984 May; 19(5):717-9. PubMed ID: 6429192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siderophore synthesis by mucoid Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Haas B; Murphy E; Castignetti D
    Can J Microbiol; 1991 Aug; 37(8):654-7. PubMed ID: 1835428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
    J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.
    Carterson AJ; Morici LA; Jackson DW; Frisk A; Lizewski SE; Jupiter R; Simpson K; Kunz DA; Davis SH; Schurr JR; Hassett DJ; Schurr MJ
    J Bacteriol; 2004 Oct; 186(20):6837-44. PubMed ID: 15466037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
    Speert DP; Farmer SW; Campbell ME; Musser JM; Selander RK; Kuo S
    J Clin Microbiol; 1990 Feb; 28(2):188-94. PubMed ID: 2107198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
    Malhotra S; Hayes D; Wozniak DJ
    J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.
    Boucher JC; Yu H; Mudd MH; Deretic V
    Infect Immun; 1997 Sep; 65(9):3838-46. PubMed ID: 9284161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.
    Pugashetti BK; Metzger HM; Vadas L; Feingold DS
    J Clin Microbiol; 1982 Oct; 16(4):686-91. PubMed ID: 6818245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.
    DeVries CA; Ohman DE
    J Bacteriol; 1994 Nov; 176(21):6677-87. PubMed ID: 7961421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of divalent cations on the synthesis of alginic acid-like exopolysaccharide from mucoid Pseudomonas aeruginosa.
    Dunne WM; Buckmire FL
    Microbios; 1985; 43(174-175):193-216. PubMed ID: 3937956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa Regulated Intramembrane Proteolysis: Protease MucP Can Overcome Mutations in the AlgO Periplasmic Protease To Restore Alginate Production in Nonmucoid Revertants.
    Delgado C; Florez L; Lollett I; Lopez C; Kangeyan S; Kumari H; Stylianou M; Smiddy RJ; Schneper L; Sautter RT; Smith D; Szatmari G; Mathee K
    J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.